1966
DOI: 10.1001/archderm.1966.01600260097016
|View full text |Cite
|
Sign up to set email alerts
|

The Chloroquine Mystery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1968
1968
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…QTc prolongation and torsade de pointes (TdP) can occur in patients after both short-term and high-dose administration of CQ and, thus, drug–drug interactions (DDI) with other QTc-prolonging drugs is a cause for concern [9] . Therefore, regular 6-month ophthalmological follow-up examinations, cardiac monitoring, complete blood counts, and blood glucose level tests are advised for patients taking either CQ or HCQ [10] .…”
Section: Introductionmentioning
confidence: 99%
“…QTc prolongation and torsade de pointes (TdP) can occur in patients after both short-term and high-dose administration of CQ and, thus, drug–drug interactions (DDI) with other QTc-prolonging drugs is a cause for concern [9] . Therefore, regular 6-month ophthalmological follow-up examinations, cardiac monitoring, complete blood counts, and blood glucose level tests are advised for patients taking either CQ or HCQ [10] .…”
Section: Introductionmentioning
confidence: 99%
“…Suppression of humoral antibody formation by chloroquine could be a specific effect since there was no significant change in the total serum protein level between the control group (7.1 k 0.36; n = 35) and the test group (6.0 f 0.70; n = 21) which was also observed with lower doses of chloroquine (1-20 mg kg-1 s.c.). Knox & Owens (1966) reported that the beneficial effect of chloroquine in the treatment of collagen disorders might involve serum IgM level; hence, the next group of experiments conducted were to determine whether chloroquine has any specific effect on serum IgM level and the plaque forming cells in the spleen of mice which synthesize IgM type of antibodies. It was observed that the number of plaque-forming cells was significantly reduced from 104.87 f 14.6 in control group to 24.43 f 10.4 in the chloroquine treated group (P < 0.01); there was also a simultaneous reduction of serum IgM levels in these mice.…”
Section: Resultsmentioning
confidence: 99%
“…Hence, before CQ and HCQ treatment, an initial cardiac evaluation is necessary for COVID-19 patients ( Zhou W. et al, 2020 ). Also, several follow-up evaluations, such as regular ophthalmological examination and cardiac monitor, are suggested for patients with short- or long-term treatment ( Knox and Owens, 1966 ). Thus, using CQ or HCQ as a COVID-19 treatment was controversial, which results from their ocular, cardiac, and neuro toxicities ( Oren et al, 2020 ; Zou et al, 2020 ).…”
Section: Antimicrobialsmentioning
confidence: 99%